40,447
Views
27
CrossRef citations to date
0
Altmetric
Commentary

Why vaccines matter: understanding the broader health, economic, and child development benefits of routine vaccination

ORCID Icon & ORCID Icon
Pages 1900-1904 | Received 08 Nov 2019, Accepted 18 Dec 2019, Published online: 24 Jan 2020

References

  • World Health Organization. World Health Organization: 10 facts on immunization; 2018 [accessed 2019 Apr 9]. https://www.who.int/features/factfiles/immunization/en/.
  • World DataBank: World Development Indicators. The World Bank; 2017. http://databank.worldbank.org/data/reports.aspx?source=world-development-indicators.
  • Ozawa S, Mirelman A, Stack ML, Walker DG, Levine OS. Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review. Vaccine. 2012;31:96–108. doi:10.1016/j.vaccine.2012.10.103.
  • Pramanik S, Agrahari K, Srivastava A, Varanasi V, Setia M, Laxminarayan R. Integrated child health and immunization survey- rounds 1 & 2. New Delhi (India): Immunization Technical Support Unit, Ministry of Health and Family Welfare, Government of India; 2016.
  • World Health Organization. Progress towards global immunization goals - 2016. Geneva (Switzerland); 2016. http://who.int/entity/immunization/monitoring_surveillance/SlidesGlobalImmunization.pptx?ua=1.
  • Murhekar M. Epidemiology of diphtheria in India, 1996–2016: implications for prevention and control. Am J Trop Med Hyg. 2017;97:313–18. doi:10.4269/ajtmh.17-0047.
  • Jalloh MF, Bennett SD, Alam D, Kouta P, Lourenço D, Alamgir M, Feldstein LR, Ehlman DC, Abad N, Kapil N. Rapid behavioral assessment of barriers and opportunities to improve vaccination coverage among displaced Rohingyas in Bangladesh, January 2018. Vaccine. 2019;37:833–38. doi:10.1016/j.vaccine.2018.12.042.
  • Chan M. Linking child survival and child development for health, equity, and sustainable development. Lancet. 2013;381:1514–15. doi:10.1016/S0140-6736(13)60944-7.
  • Shonkoff JP, Richter L, van der Gaag J, Bhutta ZA. An integrated scientific framework for child survival and early childhood development. PEDIATRICS. 2012;129:e460–72. doi:10.1542/peds.2011-0366.
  • Ozawa S, Clark S, Portnoy A, Grewal S, Stack ML, Sinha A, Mirelman A, Franklin H, Friberg IK, Tam Y. Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001–2020. Bull World Health Organ. 2017;95:629–38. doi:10.2471/BLT.16.178475.
  • Hooda SK. Out-of-pocket payments for healthcare in India. J Health Manag. 2017;19:1–15. doi:10.1177/0972063416682535.
  • Wagstaff A, Flores G, Smitz M-F, Hsu J, Chepynoga K, Eozenou P. Progress on impoverishing health spending in 122 countries: a retrospective observational study. Lancet Global Health. 2018;6:e180–92. doi:10.1016/S2214-109X(17)30486-2.
  • Riumallo-Herl C, Chang AY, Clark S, Constenla D, Clark A, Brenzel L, Verguet S. Poverty reduction and equity benefits of introducing or scaling up measles, rotavirus and pneumococcal vaccines in low-income and middle-income countries: a modelling study. BMJ Global Health. 2018;3:e000613.
  • Megiddo I, AR C, Nandi A, Chatterjee S, Prinja S, Khera A, Laxminarayan R. Analysis of the universal immunization programme and introduction of a rotavirus vaccine in India with IndiaSim. Vaccine. 2014;32(Supplement 1):A151–61.
  • Megiddo I, Klein E, Laxminarayan R. Potential impact of introducing the pneumococcal conjugate vaccine into national immunisation programmes: an economic-epidemiological analysis using data from India. BMJ Global Health. 2018;3:e000636. doi:10.1136/bmjgh-2017-000636.
  • Verguet S, Murphy S, Anderson B, Johansson KA, Glass R, Rheingans R. Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis. Vaccine. 2013;31:4902–10. doi:10.1016/j.vaccine.2013.07.014.
  • Johansson KA, Memirie ST, Pecenka C, Jamison DT, Verguet S. Health gains and financial protection from pneumococcal vaccination and pneumonia treatment in Ethiopia: results from an extended cost-effectiveness analysis. PLoS One. 2015;10:e0142691.
  • Verguet S, Olson ZD, Babigumira JB, Desalegn D, Johansson KA, Kruk ME, Levin CE, Nugent RA, Pecenka C, Shrime MG. Health gains and financial risk protection afforded by public financing of selected interventions in Ethiopia: an extended cost-effectiveness analysis. Lancet Global Health. 2015;3:e288–96. doi:10.1016/S2214-109X(14)70346-8.
  • Chang AY, Riumallo-Herl C, Perales NA, Clark S, Clark A, Constenla D, Garske T, Jackson ML, Jean K, Jit M. The equity impact vaccines may have on averting deaths and medical impoverishment in developing countries. Health Aff. 2018;37:316–24. doi:10.1377/hlthaff.2017.0861.
  • Wagstaff A, Flores G, Hsu J, Smitz MF, Chepynoga K, Buisman LR, van Wilgenburg K. Progress on catastrophic health spending in 133 countries: a retrospective observational study. Lancet Global Health. 2018;6:e169–79.
  • Verguet S, Laxminarayan R, Jamison DT. Universal public finance of tuberculosis treatment in India: an extended cost-effectiveness analysis. Health Econ. 2014;24:318–32. doi:10.1002/hec.3019.
  • Park M, Jit M, Wu JT. Cost-benefit analysis of vaccination: a comparative analysis of eight approaches for valuing changes to mortality and morbidity risks. BMC Med. 2018;16:139. doi:10.1186/s12916-018-1130-7.
  • Zhou F, Shefer A, Wenger J, Messonnier M, Wang LY, Lopez A, Moore M, Murphy TV, Cortese M, Rodewald L. Economic evaluation of the routine childhood immunization program in the United States, 2009. Pediatrics. 2014;133:577–85. doi:10.1542/peds.2013-0698.
  • Robinson LA, Hammitt JK, Jamison DT, Walker DG. Conducting benefit-cost analysis in low- and middle-income countries: introduction to the special issue. J Ben Cost Anal. 2019;10:1–14. doi:10.1017/bca.2019.4.
  • Robinson LA, Hammitt JK, O’Keeffe L. Valuing mortality risk reductions in global benefit-cost analysis. J Ben Cost Anal. 2019;10:15–50. doi:10.1017/bca.2018.26.
  • Laxminarayan R, Jamison DT, Krupnick AJ, Norheim OF. Valuing vaccines using value of statistical life measures. Vaccine. 2014;32:5065–70. doi:10.1016/j.vaccine.2014.07.003.
  • Laxminarayan R, Klein EY, Darley SR, Adeyi O. Global investments in TB control: economic benefits. Health Aff. 2009;28:w730–42. doi:10.1377/hlthaff.28.4.w730.
  • Viscusi WKK, Aldy JEJ. The value of a statistical life: a critical review of market estimates throughout the world. J Risk Uncertain. 2003;27:5–76. doi:10.1023/A:1025598106257.
  • Jamison DT, Jha P, Bloom D. The challenge of diseases. Copenhagen consensus 2008 challenge paper: diseases. Copenhagen: Copenhagen Consensus Center; 2008.
  • Jamison DT, Jha P, Laxminarayan R, Ord T. Infectious disease, injury, and reproductive health. Copenhagen: Copenhagen Consensus Center; 2012.
  • Jha P, Hum R, Gauvreau CL, Jordan K. Benefits and costs of the health targets for the post-2015 development agenda. In: Lomborg B, editor. Prioritizing development. 1st ed. Cambridge: Cambridge University Press;2018. p.219–30.
  • Ozawa S, Clark S, Portnoy A, Grewal S, Brenzel L, Walker DG. Return on investment from childhood immunization in low- and middle-income countries, 2011–20. Health Aff. 2016;35:199–207. doi:10.1377/hlthaff.2015.1086.
  • Levin CE, Sharma M, Olson Z, Verguet S, Shi JF, Wang SM, Qiao YL, Jamison DT, Kim JJ. An extended cost-effectiveness analysis of publicly financed HPV vaccination to prevent cervical cancer in China. Vaccine. 2015;33:2830–41.
  • Driessen J, Olson ZD, Jamison DT, Verguet S. Comparing the health and social protection effects of measles vaccination strategies in Ethiopia: an extended cost-effectiveness analysis. Soc Sci Med. 2015;139:115–22. doi:10.1016/j.socscimed.2015.06.018.
  • Interagency Coordination Group on Antimicrobial Resistance. No time to wait: securing the future from drug-resistant infections; 2019 https://www.who.int/antimicrobial-resistance/interagency-coordination-group/IACG_final_report_EN.pdf?ua=1.
  • Goossens H. Antibiotic consumption and link to resistance. Clin Microbiol Infect. 2009;15(Suppl 3):12–15. doi:10.1111/j.1469-0691.2009.02725.x.
  • van de Sande-bruinsma N, Grundmann H, Verloo D. Tiemersma E, Monen J, Goossens H, Ferech M. Antimicrobial drug use and resistance in Europe. Emerging Infect Dis. 2008;14:1722–30. doi:10.3201/eid1411.070467.
  • World Health Organization. Antimicrobial resistance: global report on surveillance 2014. Geneva: World Health Organization; 2014.
  • CDDEP. State of the world’s antibiotics. Washington (DC): Center for Disease Dynamics, Economics & Policy; 2015.
  • Utt E, Wells C. The global response to the threat of antimicrobial resistance and the important role of vaccines. Pharm Policy and Law. 2016;18:179–97. doi:10.3233/PPL-160442.
  • The Review on Antimicrobial Resistance chaired by Jim O’Neill. Tackling drug-resistant infections globally: final report and recommendations. London: HM Government, Wellcome Trust; 2016.
  • Bloom DE, Brenzel L, Cadarette D, Sullivan J. Moving beyond traditional valuation of vaccination: needs and opportunities. Vaccine. 2017;35:A29–35. doi:10.1016/j.vaccine.2016.12.001.
  • Global Antibiotic Resistance Partnership. Rationalizing antibiotic use to limit antibiotic resistance in India(+). Indian J Med Res 2011;134:281–94.
  • Laxminarayan R. Antibiotic effectiveness: balancing conservation against innovation. Science. 2014;345:1299–301. doi:10.1126/science.1254163.
  • Sevilla JP, Bloom DE, Cadarette D, Jit M, Lipsitch M. Toward economic evaluation of the value of vaccines and other health technologies in addressing AMR. PNAS. 2018;115:12911–19. doi:10.1073/pnas.1717161115.
  • Bloom DE, Black S, Salisbury D, Rappuoli R. Antimicrobial resistance and the role of vaccines. Proc Natl Acad Sci USA. 2018;115:12868–71. doi:10.1073/pnas.1717157115.
  • Dewey KG, Begum K. Long-term consequences of stunting in early life. Mat Child Nutr. 2011;7(Suppl 3):5–18. doi:10.1111/mcn.2011.7.issue-s3.
  • Almond D, Currie J. Killing me softly: the fetal origins hypothesis. J Econ Perspect. 2011;25:153–72. doi:10.1257/jep.25.3.153.
  • Currie J, Vogl T. Early-life health and adult circumstance in developing countries. Annu Rev Econom. 2013;5:1–36. doi:10.1146/annurev-economics-081412-103704.
  • Barker DJ. The fetal and infant origins of adult disease. BMJ. 1990;301:1111–1111. doi:10.1136/bmj.301.6761.1111.
  • Barker DJ. Fetal origins of coronary heart disease. BMJ. 1995;311:171–74. doi:10.1136/bmj.311.6998.171.
  • Adair LS, Fall CH, Osmond C, Stein AD, Martorell R, Ramirez-Zea M, Sachdev HS, Dahly DL, Bas I, Norris SA. Associations of linear growth and relative weight gain during early life with adult health and human capital in countries of low and middle income: findings from five birth cohort studies. Lancet. 2013;382:525–34. doi:10.1016/S0140-6736(13)60103-8.
  • Alderman H, Hoddinott J, Kinsey B. Long term consequences of early childhood malnutrition. Oxf Econ Pap. 2006;58:450–74. doi:10.1093/oep/gpl008.
  • Behrman JR, Calderon MC, Preston SH, Hoddinott J, Martorell R, Stein AD. Nutritional supplementation in girls influences the growth of their children: prospective study in Guatemala. Am J Clin Nutr. 2009;90:1372–79. doi:10.3945/ajcn.2009.27524.
  • Dercon S, Porter C. Live aid revisited: long-term impacts of the 1984 Ethiopian famine on children. J Eur Econ Assoc. 2014;12:927–48. doi:10.1111/jeea.12088.
  • Hoddinott J, Alderman H, Behrman JR, Haddad L, Horton S. The economic rationale for investing in stunting reduction. Matern Child Nutr. 2013;9(Suppl 2):69–82. doi:10.1111/mcn.2013.9.issue-s2.
  • Maccini S, Yang D. Under the weather: health, schooling, and economic consequences of early-life rainfall. Am Econ Rev. 2009;99:1006–26. doi:10.1257/aer.99.3.1006.
  • Maluccio J, Hoddinott J, Behrman J, Quisumbing A, Martorell R, Stein AD. The impact of nutrition during early childhood on education among guatemalan adults. Econ J. 2009;119:734–63. doi:10.1111/j.1468-0297.2009.02220.x.
  • Martorell R, Horta BL, Adair LS, Stein AD, Richter L, Fall CHD, Bhargava SK, Biswas SKD, Perez L, Barros FC. Weight gain in the first two years of life is an important predictor of schooling outcomes in pooled analyses from five birth cohorts from low- and middle-income countries. J Nutr. 2010;140:348–54. doi:10.3945/jn.109.112300.
  • Nandi A, Ashok A, Kinra S, JR B, Laxminarayan R. Early childhood nutrition is positively associated with adolescent educational outcomes: evidence from the Andhra Pradesh child and parents study (APCAPS). J Nutr. 2016;146:1–8.
  • Nandi A, Behrman JR, Bhalotra S, Deolalikar AB, Laxminarayan R. Human capital and productivity benefits of early childhood nutritional interventions. In: Bundy DAP, et al., editors. Disease control priorities third edition, volume 8: child & adolescent development. Washington (DC): World Bank Publications; 2017. p. 385–402.
  • Stein AD, Barros FC, Bhargava SK, Hao W, Horta BL, Lee N, Kuzawa CW, Martorell R, Ramji S, Stein A. Birth status, child growth, and adult outcomes in low- and middle-income countries. J Pediatr. 2013;163:1740–1746.e4. doi:10.1016/j.jpeds.2013.08.012.
  • Stein AD, Wang M, Martorell R, Norris SA, Adair LS, Bas I, Sachdev HS, Bhargava SK, Fall CHD, Gigante DP. Growth patterns in early childhood and final attained stature: data from five birth cohorts from low- and middle-income countries. Am J Hum Biol. 2010;22:353–59. doi:10.1002/ajhb.20998.
  • Victora CG, Adair L, Fall C, Hallal PC, Martorell R, Richter L, Sachdev HS. Maternal and child undernutrition: consequences for adult health and human capital. Lancet. 2008;371:340–57.
  • Nandi A, Behrman JR, Kinra S, Laxminarayan R. Early-life nutrition is associated positively with schooling and labor market outcomes and negatively with marriage rates at age 20–25 years: evidence from the Andhra Pradesh children and parents study (APCAPS) in India. J Nutr. 2018;148:140–46. doi:10.1093/jn/nxx012.
  • Nandi A, Behrman J, Laxminarayan R. The impact of a national early childhood development program on future schooling attainment: evidence from ICDS in India. Econ Dev Cult Change. 2019. In Press. doi:10.1086/703078.
  • Sørup S, Benn CS, Poulsen A, Krause TG, Aaby P, Ravn H. Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections. JAMA. 2014;311:826–35. doi:10.1001/jama.2014.470.
  • Mina MJ. Measles, immune suppression and vaccination: direct and indirect nonspecific vaccine benefits. J Infect. 2017;74(Suppl 1):S10–7. doi:10.1016/S0163-4453(17)30185-8.
  • Mina MJ, Metcalf CJE, de Swart RL, Osterhaus ADME, Grenfell BT. Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science. 2015;348:694–99. doi:10.1126/science.aaa3662.
  • Mina MJ, Kula T, Leng Y, Li M, de Vries RD, Knip M, Siljander H, Rewers M, Choy DF, Wilson MS. Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens. Science. 2019;366:599–606. doi:10.1126/science.aay6485.
  • Nandi A, Shet A, Behrman JR, Black MM, Bloom DE, Laxminarayan R Anthropometric, cognitive, and educational benefits of measles vaccination: longitudinal cohort analysis in Ethiopia, India, and Vietnam; 2018. CDDEP Working paper.
  • Driessen J, Razzaque A, Walker D, Canning D. The effect of childhood measles vaccination on school enrolment in Matlab, Bangladesh. Appl Econ. 2015;47:6019–40. doi:10.1080/00036846.2015.1061647.
  • Anekwe TD, Newell M-L, Tanser F, Pillay D, Bärnighausen T. The causal effect of childhood measles vaccination on educational attainment: A mother fixed-effects study in rural South Africa. Vaccine. 2015;33:5020–26. doi:10.1016/j.vaccine.2015.04.072.
  • Nandi A, Deolalikar AB, Bloom DE, Laxminarayan R. Haemophilus influenzae type b vaccination and anthropometric, cognitive, and schooling outcomes among Indian children. Ann N Y Acad Sci. 2019;1449:70–82. doi:10.1111/nyas.14127.
  • Upadhyay AK, Srivastava S. Association between Haemophilus influenza type B (Hib) vaccination and child anthropometric outcomes in Andhra Pradesh (India): evidence from the young lives study. J Public Health. 2017;25:581–89. doi:10.1007/s10389-017-0824-1.
  • Bloom DE, Canning D, Shenoy ES. The effect of vaccination on children’s physical and cognitive development in the Philippines. Appl Econ. 2012;44:2777–83. doi:10.1080/00036846.2011.566203.
  • Canning D, Razzaque A, Driessen J, Walker DG, Streatfield PK, Yunus M. The effect of maternal tetanus immunization on children’s schooling attainment in Matlab, Bangladesh: follow-up of a randomized trial. Soc Sci Med. 2011;72:1429–36. doi:10.1016/j.socscimed.2011.02.043.
  • Anekwe TD, Kumar S. The effect of a vaccination program on child anthropometry: evidence from India’s Universal Immunization Program. J Public Health (Oxf). 2012;34:489–97. doi:10.1093/pubmed/fds032.
  • Nandi A, Kumar S, Shet A, Bloom DE, Laxminarayan R. Childhood vaccinations and adult schooling attainment: long-term evidence from india’s universal immunisation programme. Rochester (NY): Social Science Research Network; 2019 [accessed 2019 Oct 29]. https://papers.ssrn.com/abstract=3379828.
  • Bloom DE, Canning D, Weston M. The value of vaccination. World Econ. 2005;6:15.
  • Deogaonkar R, Hutubessy R, van der Putten I, Evers S, Jit M. Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries. BMC Public Health. 2012;12:878–878. doi:10.1186/1471-2458-12-878.
  • Bloom DE, Fan VY, Sevilla JP. The broad socioeconomic benefits of vaccination. Sci Transl Med. 2018;10:eaaj2345. doi:10.1126/scitranslmed.aaj2345.
  • Constenla D, Garcia C, Lefcourt N. Assessing the economics of dengue: results from a systematic review of the literature and expert survey. Pharmacoeconomics. 2015;33:1107–35. doi:10.1007/s40273-015-0294-7.
  • Bärnighausen T, Berkley S, Bhutta ZA, Bishai DM, Black MM, Bloom DE, Constenla D, Driessen J, Edmunds J, Evans D, Reassessing the value of vaccines. Lancet Global Health. 2014;2:e251–2. doi:10.1016/S2214-109X(13)70170-0.
  • Nandi A, Shet A, Behrman JR, Black MM, Bloom DE, Laxminarayan R. Anthropometric, cognitive, and schooling benefits of measles vaccination: longitudinal cohort analysis in Ethiopia, India, and Vietnam. Vaccine. 2019;37:4336–43. doi:10.1016/j.vaccine.2019.06.025.
  • International Vaccine Access Center. The value of immunization compendium of evidence. VoICE; 2019 [accessed 2019 Oct 30]. https://immunizationevidence.org/.
  • Harvard TH Chan School of Public Health, Bill & Melinda Gates Foundation. ImmunizationEconomics.org. ImmunizationEconomics.org; 2019 [accessed 2019 Nov 7]. http://immunizationeconomics.org.
  • Saadatian-Elahi M, Horstick O, Breiman RF, Gessner BD, Gubler DJ, Louis J, Parashar UD, Tapia R, Picot V, Zinsou J-A. Beyond efficacy: the full public health impact of vaccines. Vaccine. 2016;34:1139–47. doi:10.1016/j.vaccine.2016.01.021.
  • Jit M, Hutubessy R, ME P, Sundaram N, Audimulam J, Salim S, Yoong J. The broader economic impact of vaccination: reviewing and appraising the strength of evidence. BMC Med. 2015:13. doi:10.1186/s12916-015-0446-9.